Molina Healthcare, Inc. (MOH) Shares Bought by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. lifted its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 1.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 280,388 shares of the company’s stock after purchasing an additional 3,114 shares during the quarter. Epoch Investment Partners Inc. owned 0.49% of Molina Healthcare worth $19,279,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in MOH. Tavio Capital LLC raised its position in Molina Healthcare by 418.0% in the 3rd quarter. Tavio Capital LLC now owns 537,192 shares of the company’s stock valued at $36,937,000 after buying an additional 433,485 shares during the last quarter. Koch Industries Inc. acquired a new stake in Molina Healthcare in the 2nd quarter valued at approximately $323,000. York Capital Management Global Advisors LLC acquired a new stake in Molina Healthcare in the 2nd quarter valued at approximately $19,289,000. Naya Capital Management UK Ltd. raised its position in Molina Healthcare by 225.7% in the 2nd quarter. Naya Capital Management UK Ltd. now owns 363,093 shares of the company’s stock valued at $25,119,000 after buying an additional 251,600 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its position in Molina Healthcare by 96.9% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 359,527 shares of the company’s stock valued at $24,872,000 after buying an additional 176,972 shares during the last quarter. 96.23% of the stock is currently owned by institutional investors.

Molina Healthcare, Inc. (NYSE MOH) traded down $2.22 during trading hours on Thursday, hitting $74.29. The company’s stock had a trading volume of 819,100 shares, compared to its average volume of 1,253,883. The firm has a market cap of $4,368.26, a price-to-earnings ratio of 23.76 and a beta of 0.97. Molina Healthcare, Inc. has a 52-week low of $42.56 and a 52-week high of $80.74. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.29 and a quick ratio of 1.29.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Thursday, November 2nd. The company reported ($1.62) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.23 by ($1.85). Molina Healthcare had a positive return on equity of 17.76% and a negative net margin of 1.76%. The business had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $4.95 billion. During the same quarter in the prior year, the firm posted $0.85 earnings per share. The business’s revenue was up 10.7% compared to the same quarter last year. equities research analysts forecast that Molina Healthcare, Inc. will post -3.88 EPS for the current year.

In other news, Director John C. Molina sold 15,208 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $65.79, for a total transaction of $1,000,534.32. Following the completion of the transaction, the director now directly owns 585,859 shares in the company, valued at approximately $38,543,663.61. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider William Dentino sold 67,500 shares of Molina Healthcare stock in a transaction that occurred on Monday, October 16th. The stock was sold at an average price of $61.49, for a total value of $4,150,575.00. The disclosure for this sale can be found here. Insiders have sold a total of 409,523 shares of company stock valued at $28,635,752 over the last quarter. 6.20% of the stock is currently owned by corporate insiders.

A number of brokerages recently issued reports on MOH. Jefferies Group lifted their target price on Molina Healthcare from $60.00 to $64.00 and gave the company a “hold” rating in a research report on Friday, October 13th. ValuEngine lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Wolfe Research raised Molina Healthcare from a “market perform” rating to an “outperform” rating in a research report on Monday, October 23rd. Morgan Stanley lifted their target price on Molina Healthcare from $68.00 to $89.00 and gave the company an “overweight” rating in a research report on Friday, November 3rd. Finally, Zacks Investment Research raised Molina Healthcare from a “sell” rating to a “hold” rating in a research report on Monday, November 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $64.30.

WARNING: “Molina Healthcare, Inc. (MOH) Shares Bought by Epoch Investment Partners Inc.” was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://sportsperspectives.com/2017/12/07/molina-healthcare-inc-moh-shares-bought-by-epoch-investment-partners-inc.html.

Molina Healthcare Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply